Delivery Order SPE2DE24D0013-SPE2D626F14D2
- Not listed
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, has been awarded a firm fixed-price delivery order valued at $5,645.08 by the Defense Logistics Agency Medical Supply Chain (a Department of Defense entity). The delivery order, designated XPRSMVP-10 with an ultimate completion date of November 25, 2025, carries no small business set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $3,400 firm fixed-price delivery order (XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, with an ultimate completion date of November 25, 2025. This delivery order was issued under an existing Indefinite Delivery Contract vehicle and carries no set-aside designation. The award represents a routine procurement action for molecular diagnostic supplies, consistent with Cepheid's established...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $15,456 by the Defense Logistics Agency Medical Supply Chain on December 9, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents procurement under Cepheid's established contracting relationship with the Defense Logistics Agency for...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, has been awarded a delivery order valued at $8,533.57 under contract XPRS4PLEX-10 by the Medical Supply Chain, a Defense agency entity. The award, issued on August 29, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. Performance will be conducted at Cepheid's Sunnyvale facility. This delivery order represents...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $9,216.80 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRSMVP-10 (Contract Number 4570254413), represents a continuation of the federal government's reliance on Cepheid's diagnostic capabilities. The contract utilizes no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $40,800 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents a task order under an existing Indefinite Delivery Contract vehicle. The contract is structured to procure molecular diagnostic reagents and test kits,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a delivery order valued at $4,078.80 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order, issued under contract GXGBSLBXC-10, carries no set-aside designation and represents a continuation of Cepheid's role as a primary federal supplier of diagnostic solutions, including GeneXpert...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F14D2Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $5,440 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 19, 2025. This delivery order, designated XPRS4PLEX-10, represents a non-set-aside procurement executed under Cepheid's established contracting relationship with the federal healthcare and defense procurement system. The award reflects Cepheid's substantial role as a primary federal supplier of molecular diagnostic solutions, including the GeneXpert diagnostic platform and associated reagents and test kits for detecting infectious diseases and clinical conditions. Cepheid's federal contracting portfolio demonstrates extensive engagement across multiple agencies and procurement vehicles, including significant indefinite delivery contracts with the Department of Veterans Affairs valued at $6.7 million and $32.8 million respectively, which establish ongoing procurement frameworks through 2029 and 2030. Beyond routine federal procurement, the company has engaged in federal grant work and international capacity-building initiatives focused on drug-resistant infectious disease diagnostics. This delivery order from the Defense Logistics Agency Medical Supply Chain falls within the context of broader federal reliance on Cepheid's diagnostic capabilities to support clinical laboratory operations, infectious disease testing requirements, and healthcare missions across distributed networks of military and veteran medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 12/11/25 |